Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Conatus Pharmaceutic (CNAT)

5.03 +0.21 (+4.36%)

3/27/2017  4:00pm

Open:

4.79

Pre. Close:

4.82

High:

5.09

Low:

4.76

Volume:

494,006

Market Cap:

131.63M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.21 - 5.25

5.25 - 5.32

Low:

4.52 - 4.57

4.57 - 4.67

Close:

4.85 - 4.96

4.96 - 5.13

Technical analysis  (as of: 2017-03-27 4:33:00 PM)

Overall:

      

Stoxline posted a STRONG BUY today, same as yesterday. This stock still seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 6.06     One year: 7.08

Support:

Support1: 4.62    Support2: 4.27

Resistance:

Resistance1: 5.19    Resistance2: 6.06

Pivot:

4.64

Moving Averages:

MA(5): 4.65     MA(20): 4.66

MA(100): 3.80     MA(250): 2.84

MACD:

MACD(12,26):     Signal(12,26,9): -0.02

%K %D:

%K(14,3): 67.67     %D(3): 45.77

RSI:

RSI(14): 58.46

52-Week:

High: 6.30  Low: 1.45  Change(%): 139.5

Average Vol(K):

3-Month: 593  10-Days 352

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
CNAT has closed above the upper band by 1.7%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 49.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to CNAT's normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 20 Dec 2016 14:15:00 GMT
Conatus Pharmaceuticals Inc - A Deal Emerges With Novartis As The NASH Field ...

Thu, 16 Mar 2017 15:56:15 GMT
Conatus Pharma (CNAT) Incurs Wider-than-Expected Loss in Q4

Wed, 22 Mar 2017 11:30:10 GMT
CFO Moves: Ocular Therapeutix, Conatus Pharmaceuticals

Tue, 28 Feb 2017 11:26:15 GMT
Conatus Pharmaceuticals (CNAT) Q4 Earnings: What's in Store?

Wed, 08 Mar 2017 21:00:00 GMT
Conatus Pharmaceuticals to Report Fourth Quarter and Full Year 2016 Financial ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

26.17

Shares Float (M)

23.12

% Held by Insiders

26.83

% Held by Institutions

34.40

Shares Short (K)

1040

Shares Short Prior Month (K)

1110

Stock Financials

EPS

-1.310

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

0.830

PEG Ratio

-0.14

Profit Margin

Operating Margin

-3733.42

Return on Assets (ttm)

-30.5

Return on Equity (ttm)

-105.6

Qtrly Rev. Growth

Gross Profit (p.s.)

0.031

Sales Per Share

0.031

EBITDA (p.s.)

-1.136

Qtrly Earnings Growth

Operating Cash Flow (M)

27.00

Levered Free Cash Flow (M)

17.78

FoxReading.com

Valuation

P/E

-3.84

P/E Growth Ratio

0.04

P/BV

6.06

P/S

164.74

P/CF

4.88

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.